Found 0 matching trials
Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis PHASE2 The goal of this clinical trial is to assess the safety and efficacy of rep...
Show More Location
University of Miami Hospital & Clinics - Sylvester Comprehensive Cancer Center - Neurology
Learn More & Join Trial
Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical Study N/A The primary objective of this project is to track changes over time in bala...
Show More Location
Lab for Exp Otoneurology, University Hospital Basel
Learn More & Join Trial
A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia N/A The main aim of the study was to describe the demographic and clinical char...
Show More Learn More & Join Trial
Periodontal Health Profile in Multiple Sclerosis Patients N/A This study aims to evaluate the periodontal status of patients with Multipl...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of the Effect of Pro Resolve® Sports on Treatment of Patients With Symptomatic Knee Osteoarthritis NA The GAUDI study was a randomized, multicentre, double-blind, placebo-contro...
Show More Learn More & Join Trial
Bioavailability of SPMs in Obese Humans NA Research Question: Does 4 weeks of supplementation with 'SPM Active' lead t...
Show More Location
UNC Chapel Hill Family Medicine Center
Learn More & Join Trial
IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis NA Multiple sclerosis (MS) has long been considered a disease mediated primari...
Show More Learn More & Join Trial
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis N/A The primary goal of this study is to evaluate the effects of BAF312 (siponi...
Show More Location
Jordan Research & Education Institute: Sutter Alta Bates Summit
Learn More & Join Trial
The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms NA Researchers conducted a 12-week, double-blind, randomized, placebo-controll...
Show More Location
Mind-Body Interface Research Center (MBI Lab & Care)
Learn More & Join Trial
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients N/A This study is a single cohort, central registration system, all-case, open-...
Show More Location
Novartis Investigative Site
Learn More & Join Trial